Lord, Abbett & Co’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$143M Sell
1,334,769
-228,949
-15% -$24.6M 0.46% 61
2025
Q1
$158M Buy
1,563,718
+691,454
+79% +$69.8M 0.56% 44
2024
Q4
$77.9M Sell
872,264
-68,850
-7% -$6.15M 0.25% 110
2024
Q3
$78.9M Sell
941,114
-83,474
-8% -$7M 0.25% 121
2024
Q2
$78.9M Buy
1,024,588
+1,020,936
+27,956% +$78.6M 0.26% 107
2024
Q1
$250K Sell
3,652
-82,513
-96% -$5.65M ﹤0.01% 533
2023
Q4
$4.98M Sell
86,165
-34,574
-29% -$2M 0.02% 460
2023
Q3
$6.38M Sell
120,739
-78,952
-40% -$4.17M 0.02% 434
2023
Q2
$10.8M Buy
+199,691
New +$10.8M 0.04% 411
2021
Q1
Sell
-22,862
Closed -$822K 644
2020
Q4
$822K Sell
22,862
-16,539
-42% -$595K ﹤0.01% 645
2020
Q3
$1.51M Sell
39,401
-3,248
-8% -$124K ﹤0.01% 608
2020
Q2
$1.5M Sell
42,649
-3,621
-8% -$127K 0.01% 620
2020
Q1
$1.51M Buy
+46,270
New +$1.51M 0.01% 602
2019
Q2
Sell
-167,799
Closed -$6.44M 759
2019
Q1
$6.44M Sell
167,799
-710,908
-81% -$27.3M 0.02% 625
2018
Q4
$31.1M Sell
878,707
-533,169
-38% -$18.8M 0.11% 278
2018
Q3
$54.4M Sell
1,411,876
-607,419
-30% -$23.4M 0.15% 227
2018
Q2
$66M Buy
+2,019,295
New +$66M 0.19% 168
2018
Q1
Sell
-550,228
Closed -$13.6M 832
2017
Q4
$13.6M Sell
550,228
-1,115,968
-67% -$27.7M 0.04% 568
2017
Q3
$48.6M Buy
1,666,196
+206,606
+14% +$6.03M 0.14% 223
2017
Q2
$40.5M Buy
+1,459,590
New +$40.5M 0.12% 266
2016
Q4
Sell
-1,190,686
Closed -$28.3M 872
2016
Q3
$28.3M Sell
1,190,686
-53,827
-4% -$1.28M 0.09% 367
2016
Q2
$29.1M Buy
+1,244,513
New +$29.1M 0.09% 340